Lipoprotein changes in children after liver transplantation: Mild hypertriglyceridemia and a decrease in HDL/HDL ratio
Open Access
- 1 January 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 27 (1), 175-180
- https://doi.org/10.1002/hep.510270127
Abstract
Hyperlipidemia is frequently observed in patients who undergo renal, cardiac, bone marrow, or liver transplantation, and its contribution to the long-term morbidity and survival of patients with organ transplants may be substantial. In the few studies that have focused on the pediatric age group, findings have been inconsistent. The lipoprotein profile of 10 children after liver transplantation was characterized and compared with those in normal population controls and 10 healthy siblings. Plasma triglyceride and cholesterol concentrations were determined, lipoprotein fractions (very-low-density lipoprotein [VLDL], low-density lipoprotein [LDL], and high-density lipoproteins [HDL2and HDL3]) were isolated, their chemical compositions were analyzed (protein, phospholipids, triglycerides, free cholesterol, and cholesteryl ester), and the percent relative weight composition of the particles was calculated. Plasma triglyceride and VLDL cholesterol levels were higher post-liver transplantation (P < .05): triglycerides (mean ± SD), 115.1 ± 58.7 mg% versus 76.6 ± 20.9 mg% in siblings and 60.0 ± 25.0 mg% in normal population controls; very-low-density lipoprotein cholesterol (VLDL-C), 23.0 ± 11.7 mg% versus 15.3 ± 4.7 mg% and 13.0 ± 8.0 mg%, respectively. Plasma triglyceride levels did not correlate with the length of the period after liver transplantation. Levels of LDL-C and total HDL-C and the relative weight composition of VLDL, LDL, HDL2, and HDL3 particles did not differ between post-liver transplantation children and controls. Posttransplantation, levels of HDL3, the normally predominant HDL subfraction, were decreased relative to HDL2levels (HDL3, 1.3; HDL2, 2.3). Because this observed relative increase in larger cholesteryl ester-rich HDL particles (HDL2) may result from inhibition of cholesteryl ester-triglyceride transfer processes, cholesteryl ester transfer protein activity was assayed. Cholesteryl ester transfer protein activity did not differ between patients and controls. Thus, the lipoprotein changes observed in children post-liver transplantation are mild hypertriglyceridemia and a significant increase in HDL2relative to HDL3. Because HDL2 is regarded as protective against atherosclerosis, this may be of clinical relevance.Keywords
This publication has 36 references indexed in Scilit:
- THE EFFECT OF FK506 VERSUS CYCLOSPORINE ON GLUCOSE AND LIPID METABOLISM—A RANDOMIZED TRIALTransplantation, 1994
- Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis: An assessment of clinical significance when viewed as a risk factor for cardiovascular diseaseJournal of the American Academy of Dermatology, 1992
- THE EFFECTS OF PRAVASTATIN ON HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1992
- SERUM LIPID ABNORMALITIES IN PEDIATRIC LIVER TRANSPLANT PATIENTS1Transplantation, 1992
- Hypertriglyceridemia in patients with psoriasis treated with cyclosporineJournal of the American Academy of Dermatology, 1991
- Immunosuppressive therapy and lipoprotein abnormalities after cardiac transplantationThe American Journal of Cardiology, 1991
- THE PREVALENCE OF HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1990
- Lipid Abnormalities in Pediatric Hepatic Allograft RecipientsJournal of Pediatric Gastroenterology and Nutrition, 1989
- Epidemiology as a Guide to Clinical DecisionsNew England Journal of Medicine, 1980